Olanzapine
NDC Package 70771-1817-3
Package Information
Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). Marketed by Zydus Lifesciences Limited, this product is identified by NDC 70771-1817 and is authorized under FDA application ANDA202889.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 70771 - Zydus Lifesciences Limited
- 70771-1817 - Olanzapine
- 70771-1817-3 - 30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE
- 70771-1817 - Olanzapine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (70771-1817). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 70771-1817-3 identifies a specific commercial package of 30 tablet, orally disintegrating in 1 bottle of Olanzapine, labeled by Zydus Lifesciences Limited. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Zydus Lifesciences Limited on January 18, 2025. The current certification is valid through April 29, 2025.
What are the primary indications for this medication?
Olanzapine is used to treat certain mental/mood conditions (such as schizophrenia, bipolar disorder). It may also be used in combination with other medication to treat depression. This medication can help to decrease hallucinations and help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Olanzapine belongs to a class of drugs called atypical antipsychotics. It works by helping to restore the balance of certain natural substances in the brain. Talk to the doctor about the risks and benefits of treatment (especially when used by teenagers). See also Precautions section.
How is this Zydus Lifesciences Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 70771181703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.
